(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE UM AGONISTA DE PPAR-DELTA NO TRATAMENTO DE TRANSTORNOS DE OXIDAÇÃO DE ÁCIDO GRAXO (FAOD)

ArquivadaInvention PatentPCT · US2020016430

Application data

Number

112021015063

Type

Invention Patent

Filing

02/03/2020

Publication

10/05/2021

PCT

US2020016430

Progress at the INPI

  1. Filing02/03/20
  2. Publication10/05/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 09/10/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

RENEO PHARMACEUTICALS, INC.

US

Inventors

A. D. (pessoa física)

US

C. O. (pessoa física)

US

L. P. (pessoa física)

US

N. O. (pessoa física)

US

Technical data

Priority claims

US

62/800,995 · 02/04/2019

Abstract

USO DE UM AGONISTA DE PPAR-DELTA NO TRATAMENTO DE TRANSTORNOS DE OXIDAÇÃO DE ÁCIDO GRAXO (FAOD). É descrito no presente documento o uso de agonistas de PPARd no tratamento de transtornos de oxidação de ácido graxo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

09/10/2024

RPI 2801

Parecer de pré-exame

#6.23

05/28/2024

RPI 2786

Notificação de entrada na fase nacional - PCT

#1.3

10/05/2021

RPI 2648

Alteração de dados cadastrais

#1.1

08/10/2021

RPI 2640

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.